0
0

No Surprises for COVID–19 Tests Act

12/30/2022, 4:33 AM

Summary of Bill HR 6851

Bill 117 HR 6851, also known as the No Surprises for COVID-19 Tests Act, aims to protect consumers from unexpected costs related to COVID-19 testing. The bill was introduced in response to reports of individuals receiving surprise bills for COVID-19 tests, despite the tests being covered by insurance or provided free of charge by the government.

The key provisions of the bill include:

1. Prohibiting surprise billing for COVID-19 tests: The bill would prevent healthcare providers from billing patients for COVID-19 tests that are covered by insurance or provided free of charge by the government. This would ensure that individuals are not faced with unexpected costs for essential testing. 2. Ensuring transparency in billing: The bill would require healthcare providers to clearly disclose the cost of COVID-19 tests to patients before they are administered. This would help individuals make informed decisions about their healthcare and avoid surprise bills. 3. Establishing a dispute resolution process: The bill would create a process for resolving disputes between healthcare providers and insurers over the cost of COVID-19 tests. This would help ensure that patients are not caught in the middle of billing disputes and are not held responsible for excessive charges. Overall, the No Surprises for COVID-19 Tests Act aims to protect consumers from unexpected costs related to COVID-19 testing and promote transparency in healthcare billing. By prohibiting surprise billing, ensuring transparency, and establishing a dispute resolution process, the bill seeks to provide peace of mind to individuals seeking COVID-19 testing during the ongoing pandemic.

Congressional Summary of HR 6851

No Surprises for COVID-19 Tests Act

This bill extends the temporary period during which private health insurance plans must cover testing and related services for COVID-19 without cost sharing. It also temporarily applies certain consumer protections against surprise billing to such testing and related services.

Finally, beginning on May 1, 2022, insurance plans without a negotiated price for COVID-19 testing services are no longer required to pay providers the published cash price for such services.

Current Status of Bill HR 6851

Bill HR 6851 is currently in the status of Bill Introduced since February 25, 2022. Bill HR 6851 was introduced during Congress 117 and was introduced to the House on February 25, 2022.  Bill HR 6851's most recent activity was Referred to the Subcommittee on Health. as of February 28, 2022

Bipartisan Support of Bill HR 6851

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
4
Democrat Cosponsors
4
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 6851

Primary Policy Focus

Health

Potential Impact Areas

- Cardiovascular and respiratory health
- Emergency medical services and trauma care
- Employee benefits and pensions
- Health care costs and insurance
- Health care coverage and access
- Infectious and parasitic diseases
- Medical tests and diagnostic methods

Alternate Title(s) of Bill HR 6851

No Surprises for COVID–19 Tests Act
No Surprises for COVID–19 Tests Act
To amend the Families First Coronavirus Response Act and the CARES Act to establish new coverage and payment rules for certain COVID-19 diagnostic tests and related items and services, and for other purposes.

Comments